|
HHS-Wide Stigma Workgroup
|
Research Initiative
|
CDC, FDA, HRSA, IHS, SAMHSA
|
NIMH
|
Building on the momentum of the 2019 BMC Medicine Stigma Collection and the 2019 NIMH Global Mental Health Webinar, representatives from the National Institutes of Health (NIH) formed a Stigma Planning Workgroup to harness the momentum of the 2019 BMC Medicine Stigma Collection and the 2019 NIMH Global Mental Health Webinar and to coordinate and chart a course forward for research related to stigma. The overall goal was to provide leadership, vision, and support to stigma research funded by the NIH. As the NIH-focused workgroup started to meet and gain traction, other federal partners expressed interest in joining. For example, staff from the Centers for Disease Control and Prevention (CDC), Health Resources and Services and Administration (HRSA), Indian Health Services (IHS), Food and Drug Administration (FDA), and Substance Abuse and Mental Health Services Administration (SAMHSA) joined as well. Thus, moving forward this workgroup consists of Health and Human Services (HHS) partners aiming to promote cross-cutting stigma research and related activities and to enhance opportunities for knowledge transfer and collaborative learning in the field of stigma and discrimination research.To achieve this goal, the workgroup agrees to pursue several broad actions, including: (1) Clearly defining stigma and discrimination for the purpose of the workgroup; (2) Organizing a speaker’s series to understand current stigma research findings, and interests within each federal agency; (3) Identifying and defining current stigma and discrimination research successes and challenges within each agency; (4) Identifying shared and individual priorities for each agency and how future activities could address identified challenges; (5) See enclosed list of HHS partner interests; (6) Advancing stigma and discrimination research training to build knowledge and skills among stigma-focused researchers and among other researchers seeking to increase capacity to conduct high-quality stigma and discrimination research; (7) Advancing the broader dissemination of stigma-related research; (8) Aligning technical assistance efforts to support one another; and (9) Supporting cross-cutting stigma and discrimination research as a field.
|
|
HHS/Office of the Secretary, Office of the Assistant Secretary for Planning and Evaluation (OS-ASPE) - Reentry/Criminal Justice Working |Group.
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, HRSA, SAMHSA
|
NHLBI, NIDA, NIMH
|
Through the Federal Interagency Reentry Council, federal agencies are working together to enhance community safety and well-being, assist those returning from prison and jail in becoming productive citizens, and save taxpayer dollars by lowering the direct and collateral costs of incarceration. Because reintegration to the community after incarceration intersects with issues of health, housing, education, employment, family, faith, and community well-being, the U.S Department of Health and Human Services (HHS) and other federal agencies are focusing on the reentry population with activities that aim to improve outcomes in these areas.
|
|
HIV Pre-exposure Prophylaxis (PrEP) Implementation Science in HRSA Primary Health Care Settings
|
Research Initiative
|
HRSA
|
NIMH
|
The National Institute of Mental Health (NIMH) Division of AIDS Research (DAR) collaborated with the Health Resources and Services Administration (HRSA) HIV/AIDS Bureau and Bureau of Primary Health Care to develop a research funding opportunity (NOT-MH-020-050) which aims to support implementation science on the scale-up of HIV prevention services within selected HRSA-funded health centers under the federal Ending the HIV Epidemic initiative. The funding opportunity provides one-year administrative supplements to NIH research awards that would work collaboratively with personnel at a partnering HRSA-funded health center(s) to understand and enhance their delivery of HIV testing and/or HIV pre-exposure prophylaxis (PrEP) by concurrently answering key research questions of import to the clinics as well as the wider HIV prevention community. Three applications were funded from this opportunity, and NIMH/DAR will continue to inform the HRSA Bureau of Primary Health Care on progress and outcomes, and plan for future collaboration.
|
|
HIV/AIDS Cancer Match Study (HACM)
|
Research Initiative
|
CDC
|
NCI
|
A study linking HIV and cancer registries in multiple US regions to evaluate the spectrum of cancer risk in people living with HIV
|
|
Hospice to Palliative Care: Maximizing Patient Preferences and Cost Savings
|
Research Initiative
|
AHRQ
|
CC
|
The goal of the study is to provide rational, patient-defined, evidence-based recommendations to inform the redesign of the Medicare hospice benefit, transitioning policy from the current hospice benefit to a more patient-centered palliative care model.
|
|
HRSA Advancing Precision Medicine (HRSA APM)
|
Other
|
HRSA
|
OD/AoU
|
In 2018, HRSA awarded $456K to 40 HRSA FQHCs to work on engagement activities and EHR sharing for AoU. The period of performance ran through September 2020 with some FQHCs operating on a No Cost Extension through December 2020. NIH continues to meet with HRSA monthly to discuss the potential for future opportunities to add FQHCs to the All of Us Research Program. NIH AoURP and HRSA collaborated on a workbench presentation to HRSA and all FQHCs in winter 2021. Another presentation is planned for Spring 2022.
|
|
HRSA Maternal and Child Health Bureau Grand Challenges: Promoting Pediatric Primary Prevention (P4 Challenge)
|
Meeting/ Workshop
|
CDC, CMS, HRSA
|
NICHD
|
This challenge supports innovative innovative approaches to increase well-child visits and immunizations within primary care settings. This is a HRSA/MCHB-led initiative
|
|
Human skin sensitization data set
|
Research Initiative
|
FDA
|
NIEHS
|
NICEATM and collaborators collected data for over 2,300 human predictive patch tests from more than 1,700 publications.
|
|
I-Corps @ NIH
|
Training Initiative
|
CDC
|
NCI, NCATS, NCCIH, NHGRI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIMH, NINDS
|
The I-Corps™ at the National Institutes of Health (NIH) program is focused on educating researchers and technologists on how to translate technologies from the lab into the marketplace. The program is designed to provide three-member project teams with access to instruction and mentoring in order to accelerate the translation of technologies currently being developed with NIH and the Centers for Disease Control and Prevention (CDC) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding. It is anticipated that outcomes for the I-Corps™ teams participating in this program will include significantly refined commercialization plans and well-informed pivots in their overall commercialization strategies.
|
|
IAA with FDA - Using big data to compare SARS-CoV-2 infection and therapeutic efficacy between human lung on a chip and animal model testing
|
Resource Development
|
FDA
|
NIAID
|
This collaboration will allow the development of in vitro organ on a chip technology for modeling of SARS-CoV-2 infection, identification of biomarkers and transcriptomic and tissue expression imaging by MIBI/CODEX. The data collected from the organ on a chip systems will then be compared to ongoing analysis of human clinical samples and parallel testing in animal models of COVID.
|